Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis

Ocak S., Feoli F., Fastrez J., Butenda D., Litvine C., Colin I. M., d'Odemont J-P

Source: Eur Respir Rev 2009; 18: 125-128
Journal Issue: June 2009 - 18 (112)
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ocak S., Feoli F., Fastrez J., Butenda D., Litvine C., Colin I. M., d'Odemont J-P. Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis. Eur Respir Rev 2009; 18: 125-128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


Pulmonary hypertension is common in end-stage sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008



Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002

Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005


Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011



Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics
Source: Eur Respir J 2005; 25: 783-788
Year: 2005



Pulmonary embolism, pulmonary hypertension, vasculitis
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Source: Eur Respir J 2009; 33: 371-379
Year: 2009



Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003